Utilisation of the Prestwick Chemical Library to identify drugs that inhibit the growth of mycobacteria

16Citations
Citations of this article
59Readers
Mendeley users who have this article in their library.

Abstract

Tuberculosis (TB) is an infectious bacterial disease that kills approximately 1.3 million people every year. Despite global efforts to reduce both the incidence and mortality associated with TB, the emergence of drug resistant strains has slowed any progress made towards combating the spread of this deadly disease. The current TB drug regimen is inadequate, takes months to complete and poses significant challenges when administering to patients suffering from drug resistant TB. New treatments that are faster, simpler and more affordable are urgently required. Arguably, a good strategy to discover new drugs is to start with an old drug. Here, we have screened a library of 1200 FDA approved drugs from the Prestwick Chemical library using a GFP microplate assay. Drugs were screened against GFP expressing strains of Mycobacterium smegmatis and Mycobacterium bovis BCG as surrogates for Mycobacterium tuberculosis, the causative agent of TB in humans. We identified several classes of drugs that displayed antimycobacterial activity against both M. smegmatis and BCG, however each organism also displayed some selectivity towards certain drug classes. Variant analysis of whole genomes sequenced for resistant mutants raised to florfenicol, vanoxerine and pentamidine highlight new pathways that could be exploited in drug repurposing programmes.

References Powered by Scopus

A simple statistical parameter for use in evaluation and validation of high throughput screening assays

5827Citations
N/AReaders
Get full text

Antiseptics and disinfectants: Activity, action, and resistance

3701Citations
N/AReaders
Get full text

Genes required for mycobacterial growth defined by high density mutagenesis

2144Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Synthetic Lethality through the Lens of Medicinal Chemistry

33Citations
N/AReaders
Get full text

Screening approaches and therapeutic targets: The two driving wheels of tuberculosis drug discovery

21Citations
N/AReaders
Get full text

Recent updates on novel therapeutic targets of cardiovascular diseases

13Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Kanvatirth, P., Jeeves, R. E., Bacon, J., Besra, G. S., & Alderwick, L. J. (2019). Utilisation of the Prestwick Chemical Library to identify drugs that inhibit the growth of mycobacteria. PLoS ONE, 14(3). https://doi.org/10.1371/journal.pone.0213713

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 14

61%

Researcher 8

35%

Lecturer / Post doc 1

4%

Readers' Discipline

Tooltip

Medicine and Dentistry 11

35%

Biochemistry, Genetics and Molecular Bi... 10

32%

Immunology and Microbiology 6

19%

Agricultural and Biological Sciences 4

13%

Save time finding and organizing research with Mendeley

Sign up for free